Search results

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 17 March 2021

There are currently no other licensed medicines available for treatment of LHON and current clinical practice is limited to best supportive care. The recommendation for this ultra-orphan medicine...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 17 March 2021

Company suggests that this second-generation atypical antipsychotic may provide an additional treatment option for patients with schizophrenia, in particular patients for whom it is clinically...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 17 March 2021

This is recommended for the treatment of insomnia in children and adolescents aged 2 to 18 years with autism spectrum disorder and/or Smith-Magenis syndrome, where sleep hygiene measures have been...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 17 March 2021

This is recommended for the treatment of severe atopic dermatitis in children age 6 to 11 years who are candidates for systemic therapy and where existing systemic therapies are not advisable.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 17 March 2021

This is recommended for use as an adjunctive therapy to preparations of levodopa/DOPA decarboxylase inhibitors in patients who cannot be stabilised on those combinations and for use after failure of...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 04 February 2021

This document aims to inform healthcare staff in NHS Wales about the use of NRT to manage nicotine withdrawal in adult smokers admitted to hospital. It covers initial assessment and prescribing, ...

Read Summary

Type:

Medicines Current Awareness (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 24 February 2021

Good organisation of care across interface between primary and secondary/tertiary care is crucial in ensuring that patients receive high quality care. This document updates the principles of best...

Read Summary

Type:

Medicines Current Awareness (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 25 February 2021

Updated document provides guidance for health professionals covering areas ranging from clinical responsibility, prescribing duration, foodstuffs, complementary medicine, erectile dysfunction, ...

Read Summary

Type:

Medicines Current Awareness (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group, 25 February 2021

This reminder highlights that nitrofurantoin should not be used if there are symptoms of pyelonephritis (such as fever), because it will not achieve adequate levels in renal tissue.

Read Summary

Type:

Medicines Current Awareness (Remove filter)

Source:

Macmillan Cancer Support (Remove filter)

Published by Macmillan Cancer Support, 12 April 2021

This report calls for a whole systems approach for delivery of personalised, integrated cancer care across the acute, primary, mental health and social care services.

Read Summary

Type:

Medicines Current Awareness (Remove filter)